<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>MedCity News</title>
	<link>http://www.medcitynews.com</link>
	<description>MedCity News</description>
	<lastBuildDate>Sat, 11 Feb 2012 18:02:28 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.2.1" -->

	<item>
		<title>1 in 10 doctors admit to lying to a patient (Weekend Rounds)</title>
		<description><![CDATA[A review of life science current events reported by MedCity News this week:
Are more than 10 percent of doctors liars? Survey says &#8216;yes.&#8217; About 11 percent of doctors have knowingly lied to a patient in the last year, according to a new survey published in Health Affairs.
15 healthcare Twitter hashtags you should follow. We offer [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/1-in-10-doctors-admit-to-lying-to-a-patient-in-the-last-year-weekend-rounds/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=1-in-10-doctors-admit-to-lying-to-a-patient-in-the-last-year-weekend-rounds</link>
			</item>
	<item>
		<title>Creating value with cheap medical devices (Best of MedCitizens)</title>
		<description><![CDATA[Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com. Now here's the best of what YOU had to say.]]></description>
		<link>http://www.medcitynews.com/2012/02/creating-value-with-cheap-medical-devices-best-of-medcitizens/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=creating-value-with-cheap-medical-devices-best-of-medcitizens</link>
			</item>
	<item>
		<title>Heart monitoring company CardioNet makes $6 million acquisition</title>
		<description><![CDATA[
Heart monitoring company CardioNet (NASDAQ:BEAT),which diagnoses and monitors irregular heartbeats, has acquired another cardiac monitoring company in a deal valued at more than $6 million.
The acquisition target, Ohio-based ECG Scanning &#38; Medical Services, will enable the Philadelphia, Pennsylvania-based company to expand its customer base across the Midwest, a company statement said.
CardioNet President and Chief Executive [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/heart-monitoring-company-cardionet-makes-6-million-acquisition/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=heart-monitoring-company-cardionet-makes-6-million-acquisition</link>
			</item>
	<item>
		<title>Cute Valentine&#8217;s Day quotes for health wonks: #healthpolicyvalentines</title>
		<description><![CDATA[One look at #healthpolicyvalentines will convince you that healthcare policy and Valentine&#8217;s Day emotions make for humorous (and slightly racy) bedfellows.
Twitter user Emma Sandoe, a self-described health policy budgeteer, started it all when she tweeted: &#8220;I would competitively bid for you #healthpolicyvalentines last week. And since then a gush of tweets have emanated each competing [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/cute-valentines-day-quotes-for-your-healthcare-geek-via-healthpolicyvalentines/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=cute-valentines-day-quotes-for-your-healthcare-geek-via-healthpolicyvalentines</link>
			</item>
	<item>
		<title>Radiology group Radisphere pulls in $10M in equity</title>
		<description><![CDATA[
Radisphere has landed a $10 million equity investment as the radiology company looks to expand its community hospital customer base.
Radiology outsourcing groups like Cleveland-area Radisphere have become increasingly popular with investors in recent years. The trend is being driven largely by technology advances and healthcare cost pressures, which have combined to create a lucrative market [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/radiology-group-radisphere-pulls-in-10m-in-equity/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=radiology-group-radisphere-pulls-in-10m-in-equity</link>
			</item>
	<item>
		<title>From Big Data to telemedicine, Stanford startups tackle health tech</title>
		<description><![CDATA[Four new health technology companies covering areas from Big Data to telemedicine to therapeutics made their pitches to investors and media at the StartX demo day on Thursday.
StartX is Stanford University&#8217;s nonprofit student startup accelerator, operated independently from the university. Its fifth class of startups from the fall of 2011 includes four new companies devoted [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/from-big-data-to-telemedicine-stanford-accelerator-newbies-tackle-health-tech/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=from-big-data-to-telemedicine-stanford-accelerator-newbies-tackle-health-tech</link>
			</item>
	<item>
		<title>Startupalooza highlights digital health companies: MedSonics</title>
		<description><![CDATA[MedSonics uses a handheld diagnostic ultrasound device to detect, monitor and chart bone abnormalities and fractures cheaply and more efficiently to determine whether the patient needs to be moved to a healthcare facility for an X-Ray or scan.
]]></description>
		<link>http://www.medcitynews.com/2012/02/startupalooza-highlights-digital-health-companies-medsonics/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=startupalooza-highlights-digital-health-companies-medsonics</link>
			</item>
	<item>
		<title>PPD partners with Scottish health officials on clinical trials initiative</title>
		<description><![CDATA[
PPD routinely strikes strategic partnerships with pharmaceutical companies. But the clinical research organization has entered a different kind of partnership in Scotland with the goal of  streamlining the clinical trials process and speeding the regulatory process for new therapies.
Wilmington, North Carolina-based PPD has entered an alliance with the National Health Services&#8217;s Research Scotland (NRS), the [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/ppd-partners-with-scottish-health-officials-on-clinical-trials-initiative/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ppd-partners-with-scottish-health-officials-on-clinical-trials-initiative</link>
			</item>
	<item>
		<title>Is the early stage funding valley of death a myth?</title>
		<description><![CDATA[
You can&#8217;t read much about the venture capital industry before you start hearing about the so-called &#8220;valley of death&#8221; for early stage companies.
Conventional wisdom holds that young companies enter that valley, in which attracting investment capital becomes extremely difficult, at an early stage, typically between an initial round of angel funding and the company&#8217;s first [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/is-the-early-stage-funding-valley-of-death-a-myth/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-the-early-stage-funding-valley-of-death-a-myth</link>
			</item>
	<item>
		<title>Startupalooza highlights digital health companies: Cancerlife</title>
		<description><![CDATA[Cancerlife provides a social platform for cancer center patients to communicate with supporters such as friends, family, people who share their disease and physicians. It also includes a journal to document how they are feeling. But what sets Cancerlife apart from rivals, says president and co-founder Charles Coltman, is that patients can track the side effects they experience from their medications, allowing them to work with their physicians to better tailor the level and types of medication they take. ]]></description>
		<link>http://www.medcitynews.com/2012/02/startupalooza-highlights-digital-health-companies-cancerlife/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=startupalooza-highlights-digital-health-companies-cancerlife</link>
			</item>
	<item>
		<title>Meaningful Use Attestation and Audits: A Word to the Wise</title>
		<description><![CDATA[The CMS EHR Incentive Program is going full bore. Over $390,000,000 was paid out in November alone by Medicare to Eligible Professionals (EP) and Eligible Hospitals (EH). That doesn’t even include the Medicaid incentives. Seems like every possible EHR is certified, EPs and EHs are registering, and we’ve even seen the Stage 1 early 2011 [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/meaningful-use-attestation-audits/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=meaningful-use-attestation-audits</link>
			</item>
	<item>
		<title>Startupalooza highlights digital health companies: Epion Health</title>
		<description><![CDATA[Epion Health is a digital health company focusing on improving health literacy in the one place it can be reasonably sure it will have the patient's undivided attention -- the physician's waiting room.

]]></description>
		<link>http://www.medcitynews.com/2012/02/startupalooza-highlights-digital-health-companies-epion-health/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=startupalooza-highlights-digital-health-companies-epion-health</link>
			</item>
	<item>
		<title>DePuy Orthopaedics rolls out new hip, shoulder, knee surgery technologies</title>
		<description><![CDATA[DePuy Orthopaedics launched several new surgical products this week for knee, shoulder and hip revisions.
The Johnson &#38; Johnson (NYSE:JNJ) subsidiary accounted for $5.8 billion in sales in 2011, but those sales were offset by $521 million in costs associated with the 2010 recall of its metal-on-metal ASR hip replacement system. That line of products had [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/depuy-orthopaedics-rolls-out-new-hip-shoulder-knee-surgery-technologies/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=depuy-orthopaedics-rolls-out-new-hip-shoulder-knee-surgery-technologies</link>
			</item>
	<item>
		<title>NextGen:Health offers new, dynamic type of conference, with CME</title>
		<description><![CDATA[This post is sponsored by NextGen:Health.
NextGen:Health   is a new way of doing conferences: An invitation-only live event with world-leading experts giving &#8220;TED.com-style&#8221; Talks that are DYNAMIC, INSPIRING and SHORT (between 6-18 minutes). The topics are game-changing BIG ideas on:  improving experiences of professionals, patients, and families; enabling innovation through research and data-sharing; mobile and tech; [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/nextgenhealth-offers-new-dynamic-type-of-conference-with-cme/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=nextgenhealth-offers-new-dynamic-type-of-conference-with-cme</link>
			</item>
	<item>
		<title>Teleradiology group Foundation adds another $1M in funding</title>
		<description><![CDATA[
When we last heard from Foundation Radiology Group, the radiology outsourcing company had raised $1 million last November, funding that was revealed in a regulatory document.
Now the company has filed an amended regulatory document with the U.S. Securities and Exchange Commission that indicates it&#8217;s raised another $1 million.
That&#8217;s consistent with Pittsburgh-based Foundation&#8217;s practices of not [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/teleradiology-group-foundation-adds-another-1m-in-funding/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=teleradiology-group-foundation-adds-another-1m-in-funding</link>
			</item>
	<item>
		<title>Kidney failure treatment firm raising $1M; search for $5M continues</title>
		<description><![CDATA[Kidney failure treatment startup Phraxis is seeking $1 million of which $200,000 has been raised according to a recent regulatory filing.
Earlier in an interview with MedCity News, Phraxis CEO Michael Kallok had said that the company intends to raise $5 million. After the filing, he noted that the $1 million is a bridge financing and [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/kidney-failure-treatment-firm-raising-1m-search-for-5m-continues/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=kidney-failure-treatment-firm-raising-1m-search-for-5m-continues</link>
			</item>
	<item>
		<title>FDA&#8217;s plan for approving biosimilars isn&#8217;t &#8216;one size fits all&#8217; (Morning Read)</title>
		<description><![CDATA[Current medical news from today, including FDA's draft rules for approving biosimilars, mobile health's integration into insurance, and healthcare social media makes clinical trials easier.]]></description>
		<link>http://www.medcitynews.com/2012/02/fdas-plan-for-approving-biosimilars-isnt-one-size-fits-all-morning-read/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=fdas-plan-for-approving-biosimilars-isnt-one-size-fits-all-morning-read</link>
			</item>
	<item>
		<title>CMXI&#8217;s Aldagen acquisition is no exit; stem cell payoff is still down the road</title>
		<description><![CDATA[
Cytomedix&#8216;s (OTC:CMXI) Aldagen acquisition signaled the company&#8217;s intention to establish a strong presence in regenerative medicine therapies and the deal fills needs for both companies. Aldagen, who had tried twice to go public only to withdraw both times amid poor market conditions, gets a partner interested in developing its stem cell treatments. Cytomedix gains prospective [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/cmxis-aldagen-acquisition-is-no-exit-stem-cell-payoff-is-still-down-the-road/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=cmxis-aldagen-acquisition-is-no-exit-stem-cell-payoff-is-still-down-the-road</link>
			</item>
	<item>
		<title>Artificial immune cell treatment for melanoma aims for human trials in 2013</title>
		<description><![CDATA[A new treatment for cancer that uses artificial immune cells to trigger the body to kill cancerous cells will raise a series A round this spring and look to an investigational new drug (IND) application next year.
NexImmune is an early stage biopharmaceutical company engineering artificial cells that can stimulate the immune system to treat cancer, [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/artificial-immune-cell-treatment-for-melanoma-aims-for-human-trials-in-2013/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=artificial-immune-cell-treatment-for-melanoma-aims-for-human-trials-in-2013</link>
			</item>
	<item>
		<title>House GOP wants to kill medical device tax, but are their arguments tenuous?</title>
		<description><![CDATA[
The ongoing battle to repeal the medical device tax continues with the latest campaign being led by House GOP freshman Todd Rokita from Indiana.
Rokita, along with 74 cosigners, sent a letter Monday to Speaker John Boehner that asked him to bring a bill to the floor that would essentially kill the $2.2 billion annual tax to [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/house-gop-wants-to-kill-medical-device-tax-but-are-their-arguments-tenuous/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=house-gop-wants-to-kill-medical-device-tax-but-are-their-arguments-tenuous</link>
			</item>
	<item>
		<title>CWRU researchers: Drug shows promise in reducing Alzheimer&#8217;s plaque in brain</title>
		<description><![CDATA[
A drug that&#8217;s already approved by the FDA has shown promise in clearing away a plaque in the brain that&#8217;s associated with Alzheimer&#8217;s disease, Case Western Reserve University researchers have found.
The drug, bexarotene (brand name Targretin), in mice was able to reduce levels of Beta-amyloid plaque, a protein fragment that builds up in the brains [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/cwru-researchers-drug-shows-promise-in-reducing-alzheimers-plaque-in-brain/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=cwru-researchers-drug-shows-promise-in-reducing-alzheimers-plaque-in-brain</link>
			</item>
	<item>
		<title>With $6 billion allocation, Watson aspires to add branded drugs focus</title>
		<description><![CDATA[
Watson Pharmaceuticals (NYSE:WPI) wants to add a branded drugs focus alongside its generics business and is setting aside $6 billion for acquisitions to do it, according to a report by Bloomberg.
Chief executive officer Paul Bisaro said: &#8220;Everything we need to be a branded pharma company we have, except for the sales force. &#8230; And we [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/with-6-billion-allocation-watson-aspires-to-add-branded-drugs-focus/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=with-6-billion-allocation-watson-aspires-to-add-branded-drugs-focus</link>
			</item>
	<item>
		<title>Intravenous device company lands first major customer</title>
		<description><![CDATA[




A startup that&#8217;s developed a device to better secure intravenous lines has landed its first major customer.
Linebacker said winning its first big client would help the startup build credibility for its eponymous product and expand to other healthcare systems, according to a statement from the Columbus-area company.
The company didn&#8217;t have to look far for the [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/intravenous-device-company-lands-first-major-customer/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=intravenous-device-company-lands-first-major-customer</link>
			</item>
	<item>
		<title>IA Ventures raises $105 million to invest in Big Data companies</title>
		<description><![CDATA[Big Data investor IA Ventures has raised a new $105 million fund that it will funnel into two dozen or so startups over the next three years.
The New York-based venture firm invests in &#8220;companies that create competitive advantage through data,&#8221; usually in pre-revenue stages. With its second fund, IA will try to balance its portfolio [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/ia-ventures-raises-105-million-to-invest-in-big-data-companies/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=ia-ventures-raises-105-million-to-invest-in-big-data-companies</link>
			</item>
	<item>
		<title>N.C. CRO Clinipace names new chief medical officer for Europe</title>
		<description><![CDATA[
North Carolina clinical research organization Clinipace Worldwide is flexing its muscles abroad with an executive hire that boosts the CRO&#8217;s European operations.
Dr. Jurgen Frisch has been named chief medical officer for Clinipace&#8217;s European operations. He will be based in the company&#8217;s offices in Zurich, Switzerland.
Clinipace, headquartered in Morrisville, North Carolina, has experienced considerable global growth [...]]]></description>
		<link>http://www.medcitynews.com/2012/02/n-c-cro-clinipace-names-new-chief-medical-officer-for-europe/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=n-c-cro-clinipace-names-new-chief-medical-officer-for-europe</link>
			</item>
</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk
Page Caching using disk (enhanced)

Served from: www.medcitynews.com @ 2012-02-11 13:02:45 -->
